Testosterone replacement therapy, (TRT), hypogonadism
Testosterone replacement therapy (TRT) is one treatment option for men with hypogonadism. When TRT is prescribed, effectiveness, patient compliance, cost, and potential side effects should be considered and utilized to develop an individualized treatment plan. Depo-testosterone is the most cost-efficient TRT option and is only administered every 2 weeks which may improve patient compliance, although the dose interval can be adjusted to once per week. Androderm is the most efficacious TRT medication, with up to 92% of patients reaching normal testosterone levels. Testim and Vogelxo have the fewest reported side effects. We recommend depo-testosterone as a first line treatment option.
Original Publication Citation
Luthy, K. E., Williams, C., Freeborn, D. S., & Cook, A. (2017). Comparison of testosterone replacement therapy medications in the treatment of hypogonadism. The Journal for Nurse Practitioners. Available online 27 January 2017. doi:10.1016/j.nurpra.2016.11.016
BYU ScholarsArchive Citation
Luthy, Karlen Beth; Williams, Chris; Freeborn, Donna S.; and Cook, Aaron, "Comparison of Testosterone Replacement Therapy Medications for Treatment of Hypogonadism" (2017). All Faculty Publications. 1810.
© 2017 Elsevier Ltd. All rights reserved. This is the author's submitted version of this article. The definitive version can be found at http://www.npjournal.org/article/S1555-4155(16)30716-4/pdf
Copyright Use Information